Literature DB >> 8488577

Reusable needles--a major risk factor for acute virus B hepatitis.

M Narendranathan1, M Philip.   

Abstract

We conducted a case control study to find the extent to which acute virus B hepatitis was hospital acquired. One hundred and sixty consecutive cases of acute virus B hepatitis were compared with age (+/- 3 years) and sex matched healthy hospital visitors. Exposure to reusable needles, blood or blood products, therapeutic and diagnostic procedures, common razors and sexual practices were elicited by means of a questionnaire. Only exposures in the incubation period (6 weeks to 6 months before the onset of symptoms) were included in the analysis. The odds ratio (OR) for injections for reusable needles was 6.3 [95% confidence interval (CI) = 3.8-10.6]. The OR for single injection (OR = 3.9; 95% CI = 2.0-7.3) was less than that for multiple injections (OR = 9.8; 95% CI = 3.8-26.3), showing a dose response relationship. The proportion of cases of acute virus B hepatitis attributable to hospital related exposures was 67%. Proper aseptic techniques and sterilization practices can substantially reduce the incidence of acute hepatitis B in the population.

Entities:  

Mesh:

Year:  1993        PMID: 8488577     DOI: 10.1177/004947559302300209

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  4 in total

1.  Control of occupational hepatitis B among healthcare workers in the Czech Republic, 1982 to 1995.

Authors:  J Helcl; J Cástková; C Benes; L Novotna; K A Sepkowitz; J A DeHovitz
Journal:  Infect Control Hosp Epidemiol       Date:  2000-05       Impact factor: 3.254

2.  Knowledge and Practice on Injection Safety among Primary Health Care Workers in Kaski District, Western Nepal.

Authors:  Sudesh Gyawali; Devendra Singh Rathore; P Ravi Shankar; Vikash Kumar Kc; Nisha Jha; Damodar Sharma
Journal:  Malays J Med Sci       Date:  2016-01

3.  The occurrence of hepatitis B and C viruses in Pakistani patients with chronic liver disease and hepatocellular carcinoma.

Authors:  C Y Tong; R Khan; N J Beeching; W U Tariq; C A Hart; N Ahmad; I A Malik
Journal:  Epidemiol Infect       Date:  1996-10       Impact factor: 2.451

Review 4.  Injection practices in 2011-2015: a review using data from the demographic and health surveys (DHS).

Authors:  Tomoyuki Hayashi; Yvan J-F Hutin; Marc Bulterys; Arshad Altaf; Benedetta Allegranzi
Journal:  BMC Health Serv Res       Date:  2019-08-27       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.